|
October, 2005
Aerie Pharmaceuticals Funding / Financing Report
Aerie Pharmaceuticals, Inc. Funding Announcement: October, 2005 Funding Amount: $21 million Investors: Alta Partners, Texas Pacific Group Ventures. Industry: Medical, Opthalmology Products: Drugs Agreements: Technology obtained from Duke University Medical Center, Aerie is developing pharmaceutical products for glaucoma, AR-101
Board Members: Geoff Duyk, MD, Ph.D., David Mack, Ph.D
URL: www.www.aeriepharma.com
|
|